Roche obesity drug shows 22.5% weight loss as it seeks to catch up with Lilly, Novo
Roche obesity drug shows 22.5% weight loss in Phase-II trialRoche focuses on catching Lilly in $150 billion obesity…
US FDA approves Novartis’ gene therapy for rare muscle disorder
Item 1 of 3 The company’s logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz,…